Labcorp Holdings Inc. LH

Revenue Intelligence Report • 66 quarters of SEC filing data • Updated 2026-03-16

Labcorp's revenue is forecast to grow about 16.8% year over year to roughly $19 billion, with momentum centered in core clinical testing and related services as demand accelerates. Our econometric model shows elasticities are high and rising, indicating SG&A investment is the primary growth lever and translating into outsized topline gains. Current growth attribution is roughly 36% structural/platform expansion and 64% from SG&A spend, with R&D contributing little to revenue near term. The binding constraint on growth appears to be lab capacity—the throughput and staffing needed to scale higher testing volumes. Key risk: if capacity expansion lags demand, the company could underperform the forecast, potentially pressuring utilization and margins.

Investment Thesis

At 8.3% MAPE, the model captures Labcorp Holdings Inc.'s broad revenue trajectory, though quarterly variability suggests sensitivity to external factors. Sales & marketing spend shows a 1.46x elasticity, suggesting effective go-to-market execution.

Next FY Revenue
$16.3B
+16.8% YoY
SG&A Elasticity
1.46x
Model Accuracy
8.3% MAPE
Holdout validation: The model predicted $3.2B vs the actual $3.5B — an error of 10.0%.
Note: Labcorp Holdings Inc. does not report R&D expenses separately. This analysis uses SG&A spending only.

Revenue Forecast

LH Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $3.2B $3.5B $2.6B – $3.9B -4.9% ✓ In range
Q2 2026 $3.8B $3.0B – $4.7B +13.2%
Q3 2026 $4.5B $3.6B – $5.8B +28.5%
Q4 2026 $4.1B $3.1B – $5.3B +14.5%
Q1 2027 $3.9B $2.9B – $5.2B +10.6%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Labcorp Holdings Inc.'s systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 1.007 +0.7% In line with trend 17
FQ2 (Dec–Feb) 0.9821 -1.8% In line with trend 15
FQ3 (Mar–May) 1.0406 +4.1% +4.1% above trend 15
FQ4 (Jun–Aug) 1.0142 +1.4% In line with trend 17

How Spending Drives Revenue

LH Spending Timing
Reading this chart: Each line shows the cumulative elasticity — how a 1% increase in spending translates to revenue growth over subsequent quarters. The effect builds over 4-5 quarters as investments compound.

Spending Efficiency Over Time

Time-varying analysis: A penalized spline model (GAM) tracks how the link between spending and revenue has evolved over 66 quarters. A falling elasticity means the company needs less incremental spending to sustain growth — a hallmark of operating leverage from platform scale, pricing power, or recurring-revenue streams. A rising elasticity means each percent of additional spending more readily drives revenue than before.
Current SG&A elasticity: 2.5843x
Enhanced forecast: The time-varying model (GAM) outperformed the fixed-coefficient ARDL on holdout validation (-10.0% error vs ARDL, R² = 0.959), so this report uses the GAM for its quarterly forecasts.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

Data sourced from SEC EDGAR XBRL filings. Model: ARDL (log-log) with 66 quarters. This analysis is for informational purposes only and does not constitute investment advice.